Innate sensing of microbial products promotes wound-induced skin cancer

Nature Communications

Volumn 6, Issue , 2015, Pages

  Hoste, Esther ^a,b   Arwert, Esther N ^a   Lal, Rohit ^c   South, Andrew P ^d,e   Salas Alanis, Julio C ^f   Murrell, Dedee F ^g   Donati, Giacomo ^a,b   Watt, Fiona M ^b  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f UNIVERSIDAD DE MONTERREY   (Mexico)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; HIGH MOBILITY GROUP B1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; ANTIINFECTIVE AGENT; HMGB1 PROTEIN, HUMAN; HMGB1 PROTEIN, MOUSE; MYD88 PROTEIN, MOUSE; TLR5 PROTEIN, HUMAN;

BACTERIUM; CANCER; CELLS AND CELL COMPONENTS; DISEASE INCIDENCE; ENZYME ACTIVITY; INNATE BEHAVIOR; MICROBIAL ACTIVITY; RODENT; SKIN DISORDER; TUMOR; WOUNDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CANCER INCIDENCE; CHRONIC INFLAMMATION; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; LEUKOCYTE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN DEFECT; SKIN PAPILLOMA; TISSUE INJURY; UPREGULATION; WILD TYPE; WOUND; ANIMAL; C57BL MOUSE; CHEMISTRY; CROSS BREEDING; DISEASE MODEL; FEMALE; HEMATOPOIESIS; HUMAN; IMMUNOLOGY; INFLAMMATION; INJURY; MALE; METABOLISM; MICROBIOLOGY; PATHOLOGY; SKIN; SKIN TUMOR; TRANSGENIC MOUSE;

BACTERIA (MICROORGANISMS); MUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FEMALE; FLAGELLIN; HEMATOPOIESIS; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; TOLL-LIKE RECEPTOR 5; WOUNDS AND INJURIES;

EID: 84923506581     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6932     Document Type: Article

References (42)

1. Arwert, E. N., Hoste, E. & Watt, F. M. Epithelial stem cells, wound healing and cancer. Nat. Rev. Cancer 12, 170-180 (2012).
2. Dunham, L. J. Cancer in man at site of prior benign lesion of skin or mucous membrane: a review. Cancer Res. 32, 1359-1374 (1972).
3. Fleming, M. D., Hunt, J. L., Purdue, G. F. & Sandstad, J. Marjolin's ulcer: a review and reevaluation of a difficult problem. J. Burn Care Rehabil. 11, 460-469 (1990).
4. Seifert, O. & Mrowietz, U. Keloid scarring: bench and bedside. Arch. Dermatol. Res. 301, 259-272 (2009).
5. Margolis, D. J., Bilker, W., Santanna, J. & Baumgarten, M. Venous leg ulcer: incidence and prevalence in the elderly. J. Am. Acad. Dermatol. 46, 381-386 (2002).
6. Fine, J. D., Johnson, L. B., Weiner, M., Li, K. P. & Suchindran, C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J. Am. Acad. Dermatol. 60, 203-211 (2009).
7. Haase, I., Hobbs, R. M., Romero, M. R., Broad, S. & Watt, F. M. A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J. Clin. Invest. 108, 527-536 (2001).
8. Arwert, E. N. et al. Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate. Proc. Natl Acad. Sci. USA 107, 19903-19908 (2010).
9. Hobbs, R. M., Silva-Vargas, V., Groves, R. & Watt, F. M. Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. J. Invest. Dermatol. 123, 503-515 (2004).
10. Li, N., Grivennikov, S. I. & Karin, M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer cell 19, 429-431 (2011).
11. Balkwill, F. Tumour necrosis factor and cancer. Nat. Rev. Cancer 9, 361-371 (2009).
12. Arnott, C. H. et al. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene 23, 1902-1910 (2004).
13. Mori, R., Kondo, T., Ohshima, T., Ishida, Y. & Mukaida, N. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 16, 963-974 (2002).
14. Hobbs, R. M. & Watt, F. M. Regulation of interleukin-1alpha expression by integrins and epidermal growth factor receptor in keratinocytes from a mouse model of inflammatory skin disease. J. Biol. Chem. 278, 19798-19807 (2003).
15. Andreu, P. et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer cell 17, 121-134 (2010).
16. Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115-122 (1999).
17. Medzhitov, R. et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2, 253-258 (1998).
18. Muzio, M., Ni, J., Feng, P. & Dixit, V. M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612-1615 (1997).
19. Rakoff-Nahoum, S. & Medzhitov, R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124-127 (2007).
20. Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124 (2007).
21. Ochi, A. et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J. Exp. Med. 209, 1671-1687 (2012).
22. Cataisson, C. et al. IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis. J. Exp. Med. 209, 1689-1702 (2012).
23. Mittal, D. et al. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J. 29, 2242-2252 (2010).
24. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001).
25. Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254-258 (2012).
26. Naik, S. et al. Compartmentalized control of skin immunity by resident commensals. Science 337, 1115-1119 (2012).
27. Abel, E. L., Angel, J. M., Kiguchi, K. & DiGiovanni, J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc. 4, 1350-1362 (2009).
28. Scaffidi, P., Misteli, T. & Bianchi, M. E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195 (2002).
29. Bonaldi, T. et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22, 5551-5560 (2003).
30. Petrof, G. et al. Serum levels of high mobility group box 1 correlate with disease severity in recessive dystrophic epidermolysis bullosa. Exp. Dermatol. 22, 433-435 (2013).
31. Tamai, K. et al. PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc. Natl Acad. Sci. USA 108, 6609-6614 (2011).
32. Liu, S. et al. HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers. Am. J. Physiol. Cell Physiol. 290, C990-C999 (2006).
33. Schwabe, R. F. & Jobin, C. The microbiome and cancer. Nat. Rev. Cancer 13, 800-812 (2013).
34. Gagliani, N., Hu, B., Huber, S., Elinav, E. & Flavell, R. A. The Fire Within: Microbes Inflame Tumors. Cell 157, 776-783 (2014).
35. Belkaid, Y. & Hand, T. W. Role of the microbiota in immunity and inflammation. Cell 157, 121-141 (2014).
36. Grice, E. A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192 (2009).
37. Shen, W. et al. Adaptive immunity to murine skin commensals. Proc. Natl Acad. Sci. USA 111, E2977-E2986 (2014).
38. The Human Microbiome Project consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012).
39. Grice, E. A. & Segre, J. A. Interaction of the microbiome with the innate immune response in chronic wounds. Adv. Exp. Med. Biol. 946, 55-68 (2012).
40. Gontcharova, V., Youn, E., Sun, Y., Wolcott, R. D. & Dowd, S. E. A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol. J. 4, 8-19 (2010).
41. Gardner, S. E., Hillis, S. L., Heilmann, K., Segre, J. A. & Grice, E. A. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 62, 923-930 (2013).
42. Lanzkron, S. M., Collector, M. I. & Sharkis, S. J. Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells. Blood 93, 1916-1921 (1999).